This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_LIPOSARCOMA_EXALLC for full statistics.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
247 |
4. Check minimum number of eventsNone |
247 |
5. Include endpointsNone |
247 |
6. Filter based on genotype QC (FinnGen only) |
247 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Liposarcoma
based on the number of shared cases.
Similar with more cases:
- Liposarcoma, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 247 | 90 | 157 |
| Unadjusted period prevalence (%) | 0.06 | 0.03 | 0.07 |
| Median age at first event (years) | 62.22 | 59.38 | 63.85 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 216
- Matched controls
- 2159
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C49.22
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including hip liposarcoma
838.4
65.5
61
*
8850/3-C49.2
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
53.4
49
*
C48.02
ICD-10 Finland
Malignant tumor of the retroperitoneal space liposarcoma
641.1
52.8
50
*
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
42.4
46.2
57
18
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
45.4
42
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
467.9
40.5
39
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
438.7
38.3
37
*
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
159.9
27.3
28
*
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
29.9
23.4
31
12
8850/3-C49.6
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
23.3
22
*
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
23.3
22
*
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
134.2
23.1
24
*
D48.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Retroperitoneum
89.6
22.2
24
*
D17.2
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs
27.7
21.5
29
12
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
7.7
20.8
51
83
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.0
20.2
145
732
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.7
20.1
45
63
8850/3-C49.1
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
20.1
19
*
C49.42
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen liposarcoma
+∞
18.0
17
*
8858/3-C48.0
ICD-O-3
Dedifferentiated liposarcoma of retroperitoneum
+∞
18.0
17
*
C49.12
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder liposarcoma
+∞
18.0
17
*
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
24.3
17.3
24
11
B01AB05
ATC
enoxaparin; parenteral
3.6
16.8
104
444
WF001
NOMESCO Finland
Preoperative radiotherapy
28.8
15.9
21
8
B01AB10
ATC
tinzaparin; parenteral
7.0
15.6
40
68
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
15.5
95
394
WX402
NOMESCO Finland
General anaesthesia
4.2
15.0
65
202
8850/3-C48.0
ICD-O-3
Liposarcoma, NOS, of retroperitoneum
+∞
14.7
14
*
130
Kela drug reimbursment
Malignant tumour
5.0
14.5
50
123
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
+∞
13.7
13
*
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
10.3
12.9
25
27
R4110
NOMESCO Finland
Physiotherapy
3.1
12.8
89
394
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
74.3
12.7
14
*
JN4BD
NOMESCO Finland
Extensive body CT
4.1
12.7
54
162
C49.10
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder without histology
+∞
11.6
11
*
C49.32
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax liposarcoma
+∞
11.6
11
*
8850/3-C49.4
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of abdomen
+∞
11.6
11
*
WX306
NOMESCO Finland
Lumbar epidural anesthesy
7.0
11.0
27
43
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
5.1
10.9
35
79
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
22.9
10.8
15
7
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.8
10.6
30
58
KAC00
NOMESCO Finland
Nephrectomy
115.3
10.5
11
*
C49.52
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis liposarcoma
+∞
10.5
10
*
C48.0
ICD-10 Finland
Malignant neoplasm: Retroperitoneum
+∞
10.5
10
*
8852/3-C49.2
ICD-O-3
Myxoid liposarcoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
10.5
10
*
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
8.6
10.4
22
28
A04AA02
ATC
granisetron; systemic, transdermal
5.2
10.0
31
67
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
57.6
9.7
11
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.9
9.7
32
74
C48.09
ICD-10 Finland
Malignant tumor of the retroperitoneal space other or unspecified tumor
104.4
9.5
10
*
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
11.4
9.5
17
16
R4120
NOMESCO Finland
Occupational therapy
4.8
9.3
31
73
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
10.7
9.2
17
17
KAC10
NOMESCO Finland
Total nephrectomy with capsule
16.5
9.2
14
9
TPH07
NOMESCO Finland
Cathetrisation of artery
3.6
9.1
43
140
XX3DW
NOMESCO Finland
Time consuming IT work
3.6
9.0
43
141
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
10.7
8.7
16
16
JN4AD
NOMESCO Finland
Body CT examination
4.2
8.6
33
89
C48.00
ICD-10 Finland
Malignant tumor of the retroperitoneal space without histology
93.5
8.5
9
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
3.4
8.5
42
142
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
8.4
8
*
C49.62
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the trunk, unspecified localization liposarcoma
+∞
8.4
8
*
H02AB02
ATC
dexamethasone; systemic
3.6
8.3
39
126
ZXA05
NOMESCO Finland
Left side
2.5
8.3
77
388
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
13.7
8.0
13
10
D17.9
ICD-10 Finland
Benign lipomatous neoplasm, unspecified
13.7
8.0
13
10
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.4
8.0
89
491
S18
ICPC
Laceration/cut
2.3
7.9
109
661
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
6.6
7.7
19
31
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
4.4
7.6
27
68
C49.02
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck liposarcoma
82.8
7.5
8
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
11.4
7.4
13
12
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
7.8
7.3
16
22
8851/3-C49.2
ICD-O-3
Liposarcoma, well differentiated, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
7.3
7
*
N02BE01
ATC
paracetamol; systemic, rectal
3.0
7.3
192
1576
JAH00
NOMESCO Finland
Laparotomy
8.4
7.2
15
19
ZXA00
NOMESCO Finland
Right side
2.4
7.2
74
385
NBR20
NOMESCO Finland
Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm
31.1
7.2
9
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.9
7.0
22
49
TPX10
NOMESCO Finland
Implantation of vascular injection port
7.6
6.8
15
21
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
7.6
6.8
15
21
L03AA14
ATC
lipegfilgrastim; parenteral
10.5
6.6
12
12
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.5
6.5
18
35
JFB43
NOMESCO Finland
Left hemicolectomy
71.9
6.5
7
*
C49.19
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor
+∞
6.3
6
*
8850/3-C49.5
ICD-O-3
Liposarcoma, NOS, of connective, Subcutaneous and other soft tissues of pelvis
+∞
6.3
6
*
C49.99
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue other or unspecified tumor
+∞
6.3
6
*
YJ1BD
NOMESCO Finland
Extensive CT examination of abdomen for dose design of radiotherapy
+∞
6.3
6
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.7
6.2
20
46
A03FA01
ATC
metoclopramide; systemic, rectal
2.4
6.2
59
296
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
10.5
6.1
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
160
967
2.86
13.96
6.0
4.1
—
—
—
0
0
95
513
2.38
9.47
3.6
2.3
—
—
—
0
0
76
394
2.34
8.13
4.1
3.1
2.5
2.5
mmol/l
0.17
63
348
136
922
2.06
7.13
7.2
4.7
34.1
35.2
g/l
1.42
127
864
159
1159
2.04
6.62
14.4
10.2
4.3
4.2
e9/l
0.12
144
1018
49
229
2.42
6.50
9.0
7.9
118.6
121.9
g/l
0.60
49
222
55
272
2.31
6.43
8.3
7.4
0.3
0.9
mmol/l
0.69
47
216
55
272
2.31
6.43
8.4
7.3
13.9
11.8
kpa
2.55
55
261
55
272
2.31
6.43
8.4
7.3
5.3
5.0
kpa
2.52
55
260
97
599
2.02
6.42
3.3
3.0
0.6
0.4
e6/l
0.19
72
445
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
20
62
3.42
5.58
3.1
2.2
0.3
0.4
u/ml
0.38
12
32
35
151
2.54
5.48
3.7
2.9
51.3
60.4
ml/min/173m2
0.77
12
69
31
126
2.67
5.46
10.3
9.2
24.3
24.4
mmol/l
0.05
31
118
139
1015
1.84
5.24
9.1
7.2
1.2
1.2
mmol/l
1.44
115
864
131
946
1.82
5.06
8.5
6.0
1.2
1.2
mmol/l
0.58
123
862
44
221
2.21
4.90
5.1
3.4
—
—
—
0
0
195
1606
2.02
4.85
11.9
7.9
83.5
78.6
u/l
0.71
190
1512
227
1989
2.74
4.79
22.7
15.4
34.5
24.8
mg/l
3.41
207
1617
110
785
1.72
4.19
3.5
3.1
—
—
—
0
0
99
689
1.73
4.11
6.7
3.4
2.4
2.3
mmol/l
0.31
85
600
31
147
2.27
3.95
1.2
1.5
—
—
—
0
0
43
242
1.94
3.52
3.6
4.7
3.4
36.6
ug/l
1.02
35
207
36
194
2.00
3.33
9.3
6.7
1.0
1.4
mmol/l
1.94
36
188
55
342
1.78
3.30
3.6
3.2
0.8
0.8
mmol/l
0.17
55
323
124
975
1.55
2.87
4.2
3.7
0.0
0.0
estimate
0.00
30
187
56
368
1.67
2.74
2.8
2.6
0.9
1.0
e6/l
0.13
30
208
123
975
1.52
2.69
5.3
5.0
0.0
0.0
estimate
0.00
28
188
12
275
0.41
2.50
3.3
4.8
30.5
31.1
%
—
6
181
123
992
1.48
2.38
4.3
3.8
0.0
0.0
estimate
0.00
29
179
39
242
1.73
2.34
1.6
1.8
—
—
—
0
0
229
2129
2.04
2.27
29.2
18.4
85.0
81.4
umol/l
0.89
229
2129
39
248
1.68
2.15
1.7
1.8
—
—
—
0
0
46
307
1.61
2.11
2.5
2.3
2.2
2.3
g/l
0.86
46
282
51
353
1.56
2.01
3.1
2.8
2.1
2.1
e6/l
0.01
26
196
209
1909
1.62
1.99
23.9
14.2
77.0
78.7
ml/min/173m2
0.52
182
1577
18
94
1.99
1.85
6.2
3.5
22.9
24.1
mmol/l
0.83
18
83
195
1763
1.50
1.85
27.1
16.3
38.2
39.9
%
1.52
144
1213
13
61
2.19
1.75
1.0
1.2
—
—
—
0
0
72
556
1.42
1.65
5.0
3.9
0.0
0.0
estimate
0.00
30
180
227
2139
1.76
1.63
14.8
11.0
28.1
26.7
u/l
0.51
218
2057
5
14
3.62
1.62
1.8
2.3
—
—
—
0
0
5
15
3.38
1.53
1.0
1.7
13.4
14.8
u/l
—
5
15
94
769
1.36
1.51
4.5
3.9
—
—
—
0
0
24
149
1.68
1.47
7.8
7.3
24.6
24.0
mmol/l
0.60
24
140
56
422
1.42
1.46
4.2
3.5
66.3
239.5
ng/l
1.24
49
352
5
16
3.17
1.44
2.6
1.8
—
—
—
0
0
6
22
2.77
1.44
2.3
1.8
—
—
—
0
0
28
184
1.59
1.39
4.7
3.7
0.8
1.9
mmol/l
1.21
23
135
0
39
0.00
1.35
0.0
1.6
—
204.6
—
0
19
6
24
2.54
1.31
1.0
1.4
237.8
251.4
u/l
—
6
24
11
55
2.05
1.29
1.5
1.4
—
—
—
0
0
11
55
2.05
1.29
1.3
1.3
—
—
—
0
0
47
354
1.40
1.23
1.7
1.8
—
—
—
0
0
5
19
2.66
1.22
1.0
1.3
15.2
10.1
u/l
—
5
19
15
86
1.79
1.22
4.1
2.1
358.5
796.1
ug/l
0.39
15
80
46
346
1.40
1.21
4.5
2.1
31.6
29.3
s
1.85
46
331
0
33
0.00
1.17
0.0
2.3
—
34.7
—
0
9
5
20
2.53
1.15
1.8
1.5
—
—
—
0
0
7
30
2.37
1.13
2.4
1.7
—
—
—
0
0
5
21
2.41
1.09
1.8
3.3
—
—
—
0
0
8
148
0.53
1.07
2.3
3.5
5.0
5.0
kpa
—
8
136
5
22
2.30
1.04
1.0
1.1
—
—
—
0
0
5
22
2.30
1.04
1.2
1.1
—
—
—
0
0
7
34
2.09
1.03
1.3
1.5
—
—
—
0
0
7
34
2.09
1.03
1.3
1.5
—
—
—
0
0
34
253
1.40
0.97
3.5
4.4
198.9
242.5
u/l
4.32
34
241
63
517
1.29
0.95
2.2
2.0
2.8
3.3
mg/l
0.81
55
452
40
307
1.36
0.95
28.6
23.0
1.5
1.3
inr
—
6
34
10
55
1.85
0.93
1.1
1.7
—
—
—
0
0
14
86
1.67
0.93
2.8
1.8
—
—
—
0
0
6
28
2.17
0.92
1.0
1.1
—
—
—
0
0
8
44
1.84
0.86
1.9
1.3
—
—
—
0
0
25
183
1.41
0.79
6.9
6.6
11.2
9.8
mmol/l
0.40
25
174
8
48
1.69
0.79
1.3
1.4
—
—
—
0
0
9
53
1.72
0.76
1.1
1.2
—
—
—
0
0
9
53
1.72
0.76
1.1
1.2
—
—
—
0
0
161
1496
1.22
0.75
3.3
4.1
13.0
12.5
mm/h
0.17
145
1368
9
55
1.66
0.74
1.3
1.2
—
—
—
0
0
7
39
1.82
0.73
2.4
1.8
—
—
—
0
0
5
26
1.94
0.71
1.0
1.2
—
1.4
—
0
8
5
29
1.74
0.64
1.2
1.5
—
—
—
0
0
53
449
1.23
0.62
2.0
1.7
1.2
1.4
mg/l
0.37
43
364
65
564
1.21
0.61
2.8
2.8
387.8
7331.5
umol/l
2.61
56
476
78
876
0.84
0.60
3.6
4.0
49.7
43.4
ng/l
0.16
65
654
141
1310
1.18
0.60
2.8
3.1
71.5
52.6
u/l
0.53
132
1229
8
53
1.53
0.59
2.3
1.8
—
—
—
0
0
6
35
1.73
0.58
2.3
1.6
—
—
—
0
0
6
37
1.64
0.56
2.3
1.5
—
—
—
0
0
187
1789
1.19
0.52
4.1
4.4
1.9
2.0
mu/l
0.59
165
1607
6
40
1.51
0.52
2.3
1.6
—
—
—
0
0
150
1415
1.15
0.48
3.5
3.6
15.0
14.9
pmol/l
0.10
132
1260
38
446
0.83
0.47
1.8
1.8
225000380.2
446.8
pmol/l
0.49
32
372
11
78
1.43
0.44
1.8
2.9
—
—
—
0
0
47
536
0.85
0.43
1.7
1.7
1.6
1.4
mmol/l
0.59
34
447
11
79
1.41
0.41
4.8
3.9
3.8
3.9
mmol/l
0.72
11
72
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
0
17
0.00
0.41
0.0
1.3
—
12.2
—
0
6
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
6
45
1.34
0.34
2.3
1.6
—
—
—
0
0
6
86
0.69
0.33
1.7
1.8
—
—
—
0
0
17
137
1.26
0.33
1.3
1.3
—
—
—
0
0
34
388
0.86
0.32
1.2
1.2
0.7
1.9
u/ml
—
8
108
7
53
1.33
0.31
2.4
1.8
—
—
—
0
0
31
273
1.15
0.26
12.2
7.9
—
—
—
0
0
30
265
1.15
0.25
1.5
1.4
—
—
—
0
0
5
39
1.29
0.23
1.0
1.4
—
—
—
0
0
27
304
0.87
0.22
1.3
1.2
7.1
13.3
u/ml
—
10
117
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
9.5
—
0
10
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
0
12
0.00
0.21
0.0
2.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.9
—
—
—
0
0
0
13
0.00
0.21
0.0
1.7
—
868.5
—
0
13
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
37
404
0.90
0.19
1.8
1.7
1100.6
1212.7
nmol/l
0.22
28
309
10
121
0.82
0.18
1.5
1.8
—
—
—
0
0
68
644
1.08
0.17
3.3
2.1
156.9
342.7
u/l
0.93
68
607
81
773
1.07
0.17
2.2
2.3
74.0
76.7
nmol/l
0.42
75
678
16
139
1.16
0.16
1.3
1.6
—
—
—
0
0
13
151
0.85
0.16
1.2
1.7
—
—
—
0
0
6
78
0.76
0.16
1.7
1.6
—
—
—
0
0
21
188
1.13
0.15
1.3
1.4
—
—
—
0
0
85
816
1.06
0.15
4.4
4.5
21.8
21.0
%
0.18
39
398
7
88
0.79
0.15
1.1
1.0
—
—
—
0
0
14
122
1.16
0.14
1.0
1.2
—
49.5
—
0
10
10
86
1.17
0.11
1.2
1.3
—
—
—
0
0
194
1964
0.94
0.11
4.7
4.9
6.3
6.1
mmol/l
1.18
173
1790
35
329
1.07
0.11
1.2
1.2
45.6
33.0
iu/ml
0.19
14
105
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
6
55
1.09
0.09
1.2
1.4
—
—
—
0
0
61
589
1.05
0.08
2.9
3.0
0.6
0.8
ug/l
1.15
47
396
52
501
1.05
0.08
1.5
1.6
20.5
20.4
nmol/l
0.01
47
417
6
71
0.84
0.07
2.5
5.1
33.7
144.9
mg/l
—
6
53
6
71
0.84
0.07
2.5
5.1
27.5
33.7
mg/l
—
6
55
197
1988
0.96
0.07
4.1
4.7
4.6
4.5
mmol/l
0.18
180
1826
73
712
1.04
0.06
3.3
3.1
2008.2
1265.1
ng/l
0.78
67
611
192
1907
1.03
0.04
5.6
6.2
40.6
40.6
mmol/mol
0.00
174
1772
110
1112
0.98
0.03
2.8
2.6
—
—
—
0
0
204
2030
1.03
0.03
4.7
5.3
2.7
2.7
mmol/l
0.37
186
1847
197
1980
0.98
0.02
4.0
4.7
1.4
1.4
mmol/l
1.56
178
1800
103
1023
1.01
0.01
5.0
5.1
2.2
2.6
ug/l
0.28
91
915
10
106
0.94
0.01
1.5
1.7
—
—
—
0
0
191
1912
1.00
0.00
3.6
4.2
1.4
1.3
mmol/l
0.96
169
1732
83
828
1.00
0.00
1.9
2.0
92.7
94.2
pmol/l
0.11
45
437
10
96
1.04
0.00
2.0
2.2
31.1
39.9
u/l
—
10
87
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
7
69
1.01
0.00
2.3
1.6
39.1
45.9
nmol/l
—
7
64
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
4.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
4.3
—
—
—
0
0
6
59
1.02
0.00
1.3
1.7
—
—
—
0
0
6
61
0.98
0.00
1.5
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_LIPOSARCOMA – Liposarcoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).